Want to see PSX full AI Analyst Report?
Revenue by Segment
Breaks down sales across different business units, indicating where the company is generating the most income and potential areas for growth or concern.The business mix shifted from a 2022 commodity‑cycle peak in refining and marketing toward a more diversified profile: midstream recovered after 2023 softness and is trending higher on commercial wins and pipeline optionality, renewables became a visible revenue contributor starting mid‑2024 (but remains quarter‑to‑quarter volatile), and chemicals show limited topline yet outsized margin importance. Management’s guidance to run refining and CPChem hard, push midstream EBITDA growth and keep renewables above nameplate suggests durability, but mark‑to‑market and working‑capital swings keep near‑term cash volatility elevated.
Date | Corporate and Other | Midstream | Chemicals | Refining | Marketing and Specialties | Renewable Fuels |
|---|---|---|---|---|---|---|
Jun 30, 2026 | $9.00M | $5.23B | $0.00 | $1.62B | $31.30B | $849.00M |
Mar 31, 2026 | $10.00M | $4.72B | $0.00 | $7.77B | $19.54B | $496.00M |
Dec 31, 2025 | $8.00M | $4.75B | $0.00 | $6.81B | $21.67B | $876.00M |
Sep 30, 2025 | $9.00M | $4.47B | $0.00 | $7.26B | $22.01B | $765.00M |
Jun 30, 2025 | $10.00M | $4.53B | $0.00 | $7.11B | $20.90B | $781.00M |
Mar 31, 2025 | $10.00M | $4.83B | $0.00 | $5.70B | $19.16B | $728.00M |
Dec 31, 2024 | $7.00M | $4.46B | $0.00 | $7.67B | $20.45B | $1.10B |
Sep 30, 2024 | $10.00M | $3.80B | $0.00 | $8.79B | $22.38B | $548.00M |
Jun 30, 2024 | $8.00M | $3.63B | $0.00 | $9.20B | $24.95B | $350.00M |
Mar 31, 2024 | $10.00M | $4.12B | $0.00 | $9.13B | $22.55B | $0.00 |